HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review.

AbstractBACKGROUND:
Preinjury use of antiplatelet agents (e.g., clopidogrel and aspirin) is a risk factor for increased morbidity and mortality for patients with traumatic intracranial hemorrhage (tICH). Some investigators have recommended platelet transfusion to reverse the antiplatelet effects in tICH. This evidence-based medicine review examines the evidence regarding the impact of platelet transfusion on emergency department (ED) patients with preinjury antiplatelet use and tICH on patient-oriented outcomes.
METHODS:
The MEDLINE, EMBASE, Cochrane Library, and other databases were searched. Studies were selected for inclusion if they compared platelet transfusion with no-platelet transfusion in the treatment of adult ED patients with preinjury antiplatelet use and tICH and reported rates of mortality, neurocognitive function, or adverse effects. We assessed the quality of the included studies using standard criteria.
RESULTS:
Five retrospective, registry-based studies were identified, which enrolled 635 patients cumulatively. Based on standard criteria, three studies were of low-quality evidence, and two studies were of very low-quality evidence. One study reported higher in-hospital mortality for patients with platelet transfusion (relative risk, 2.42; 95% confidence interval, 1.2-4.9); another showed a lower mortality rate for patients receiving platelet transfusion (relative risk, 0.21; 95% confidence interval, 0.05-0.95). Three studies did not show any statistical difference in comparing mortality rates between the groups. No studies reported intermediate or long-term neurocognitive outcomes or adverse events.
CONCLUSION:
Five retrospective registry studies with suboptimal methodologies provide inadequate evidence to support the routine use of platelet transfusion in adult ED patients with preinjury antiplatelet use and tICH.
LEVEL OF EVIDENCE:
Systematic review, level III.
AuthorsDaniel K Nishijima, Shahriar Zehtabchi, Jeanette Berrong, Eric Legome
JournalThe journal of trauma and acute care surgery (J Trauma Acute Care Surg) Vol. 72 Issue 6 Pg. 1658-63 (Jun 2012) ISSN: 2163-0763 [Electronic] United States
PMID22695437 (Publication Type: Comparative Study, Journal Article, Review, Systematic Review)
CopyrightCopyright © 2012 by Lippincott Williams & Wilkins.
Chemical References
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin
Topics
  • Adult
  • Aspirin (adverse effects, therapeutic use)
  • Clopidogrel
  • Cohort Studies
  • Emergency Service, Hospital
  • Evidence-Based Medicine
  • Female
  • Hospital Mortality (trends)
  • Humans
  • Injury Severity Score
  • Intracranial Hemorrhage, Traumatic (etiology, mortality, therapy)
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors (administration & dosage, adverse effects)
  • Platelet Transfusion (methods)
  • Prognosis
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Ticlopidine (adverse effects, analogs & derivatives, therapeutic use)
  • Trauma Centers
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: